课题基金 / 基金详情

SOLID TUMOR PHARMACOLOGY CORE

SOLID TUMOR PHARMACOLOGY CORE
实体瘤药理学核心
批准号:
7314019
负责人:
CLINTON F STEWART
金额:
$31.26万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2012-07-31

项目摘要

项目成果

CLINTON F STEWART的其他基金

相似基金

相关文献

中文摘要
翻译
实体瘤药理学核心的职能是: A.进行测定,以定量采集的生物样本中的药物和药物代谢产物浓度 作为本项目临床前和临床药代动力学研究的一部分。 B。分析从临床前和临床药代动力学研究中获得的药代动力学数据, 根据研究者的要求,为数据建立适当的药代动力学和药效学模型, 程序. C.对本项目内开展的临床试验的患者样本进行基因分型研究。 D.维护实体瘤药理学核心中进行的分析数据的计算机数据库, 并根据需要生成数据检索和报告。 E.根据需要执行额外的特殊实验室程序,以支持本文件中包含的项目。 程序.
英文摘要
The functions of the Solid Tumor Pharmacology Core are to: A. Perform assays to quantitate drug and drug metabolite concentrations in biological specimens collected from animals and patients as part of preclinical and clinical pharmacokinetic studies within this Program. B. Analyze pharmacokinetic data obtained from preclinical and clinical pharmacokinetic studies, and fit appropriate pharmacokinetic and pharmacodynamic models to the data, as requested by investigators in this Program. C. Perform genotyping studies on patient samples from clinical trials conducted within this Program. D. Maintain computer databases of data from analyses performed in the Solid Tumor Pharmacology Core, and generate data retrievals and reports as required. E. Perform additional special laboratory procedures as required to support the projects included in this Program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anticancer Drug Pharmacology in Very Young Children
Anticancer Drug Pharmacology in Very Young Children
Anticancer Drug Pharmacology in Very Young Children
Anticancer Drug Pharmacology in Very Young Children
海外基金